Table 1 Characteristics of participants in the two groups
Parameter | Total | Welfare status | P value | |
|---|---|---|---|---|
Non-welfare | Welfare | Non-welfare versus Welfare | ||
N (%) | 106 (100) | 90 (84.9) | 16 (15.1) | – |
Age, years | 66.9 ± 10.8 | 67.0 ± 11.0 | 66.3 ± 10.0 | 0.810 |
Female sex, n (%) | 45 (42.5) | 40 (44.4) | 5 (31.3) | 0.325 |
BMI, kg/m2 | 21.5 [19.6, 24.3] | 21.5 [19.6, 24.3] | 22.9 [19.6, 25.1] | 0.589 |
HD vintage, year | 7.9 [2.9, 12.3] | 8.4 [3.0, 12.5] | 6.9 [2.8, 8.8] | 0.218 |
Diabetes, n (%) | 38 (35.8) | 27 (30.0) | 11 (68.8) | 0.003* |
History of immunosuppressant use, n (%) | 7 (6.6) | 7 (7.8) | 0 (0) | 0.248 |
IPAQ-SF, METs × minutes/week | 724.5 [192, 2079] | 823.5 [266.0, 1891.5] | 357.0 [0, 2423.0] | 0.292 |
Hb, g/dL | 11.1 [10.7, 11.7] | 11.1 [10.8, 11.7] | 10.8 [10.5, 11.5] | 0.246 |
CRP, mg/dL | 0.12 [0.05, 0.31] | 0.10 [0.05, 0.26] | 0.25 [0.06, 0.44] | 0.162 |
Alb, g/dL | 3.6 ± 0.3 | 3.6 ± 0.3 | 3.5 ± 0.3 | 0.370 |
cCa, mg/dL | 9.0 ± 0.7 | 9.0 ± 0.7 | 8.8 ± 0.8 | 0.206 |
P, mg/dL | 5.4 ± 1.1 | 5.4 ± 1.1 | 4.9 ± 1.0 | 0.103 |
iPTH, pg/mL | 199.1 [119.0, 277.2] | 202.6 [121.4, 281.0] | 129.8 [111.4, 253.4] | 0.370 |
25(OH)D, ng/mL | 14.3 [11.0, 18.9] | 14.8 [11.2, 19.9] | 11.5 [8.7, 14.0] | 0.005* |
VD category (deficiency/non-deficiency), n | 32/74 | 24/66 | 8/8 | 0.061 |